Fei Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fei Yang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Haoyang Hu
Department of Neurology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China
4 shared publications- Haoyang Hu
The First Medical Center, Chinese PLA General Hospital Beijing China
2 shared publications Guanglei Wang
The First Medical Center, Chinese PLA General Hospital Beijing China
1 shared publicationHong Zhao
The First Medical Center, Chinese PLA General Hospital Beijing China
1 shared publication- Hong Zhao
The First Medical Center, Chinese PLA General Hospital Beijing China
1 shared publication Jiaxuan Peng
Department of Neurology, The First Medical Centre, Chinese PLA General Hospital, Beijing, 100853, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 23 October 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (10) , e70505
Regional Heterogeneity in Ischemic Heart Disease and Ischemic Stroke Burden in Europe, 1990–2023: GBD 2023 and Complementary Mendelian Randomization Evidence
Background: Ischemic heart disease (IHD) and ischemic stroke (IS) remain major contributors to health loss in Europe, with regional heterogeneity. Comparisons of burden, attributable risks, and genetic evidence remain limited. Methods: Global Burden of Disease (GBD) 2023 estimates for Central, Eastern, and Western Europe from 1990 to 2023 were analyzed. Age‐standardized prevalence, incidence, mortality, and disability‐adjusted life‐year rates were summarized; temporal trends were assessed by Joinpoint regression and 2023 cross‐country concordance by Spearman correlation. GBD risk profiles were compared between 1990 and 2023. Complementary Mendelian randomization (MR) evaluated high blood pressure, fasting glucose, and low‐density lipoprotein cholesterol (LDL‐C). Results: Eastern Europe had the highest 2023 burden. IHD and IS rates were positively concordant across countries (Spearman ρ = 0.681–0.820; all p < 0.001), and regional 1990–2023 average annual percent changes were negative. High systolic blood pressure and high LDL‐C remained leading GBD‐attributable risks. In MR, genetic liability to high blood pressure was associated with IHD (odds ratio [OR] = 1.354, 95% confidence interval [CI] 1.281–1.433) and IS (OR = 1.351, 95% CI 1.295–1.409), and LDL‐C with IHD (OR = 1.610, 95% CI 1.508–1.719); these met the Bonferroni threshold. Fasting glucose showed nominal evidence for IHD, whereas fasting glucose and LDL‐C showed no statistically significant associations with overall IS. Conclusions: IHD and IS burdens declined across Europe, but regional inequalities persisted. GBD attribution and MR provide complementary evidence; cardiometabolic risks remain central, while genetic associations differ between IHD and overall IS.
- 23 October 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (10) , e70505
Open AccessRegional Heterogeneity in Ischemic Heart Disease and Ischemic Stroke Burden in Europe, 1990–2023: GBD 2023 and Complementary Mendelian Randomization Evidence
Background: Ischemic heart disease (IHD) and ischemic stroke (IS) remain major contributors to health loss in Europe, with regional heterogeneity. Comparisons of burden, attributable risks, and genetic evidence remain limited. Methods: Global Burden of Disease (GBD) 2023 estimates for Central, Eastern, and Western Europe from 1990 to 2023 were analyzed. Age‐standardized prevalence, incidence, mortality, and disability‐adjusted life‐year rates were summarized; temporal trends were assessed by Joinpoint regression and 2023 cross‐country concordance by Spearman correlation. GBD risk profiles were compared between 1990 and 2023. Complementary Mendelian randomization (MR) evaluated high blood pressure, fasting glucose, and low‐density lipoprotein cholesterol (LDL‐C). Results: Eastern Europe had the highest 2023 burden. IHD and IS rates were positively concordant across countries (Spearman ρ = 0.681–0.820; all p < 0.001), and regional 1990–2023 average annual percent changes were negative. High systolic blood pressure and high LDL‐C remained leading GBD‐attributable risks. In MR, genetic liability to high blood pressure was associated with IHD (odds ratio [OR] = 1.354, 95% confidence interval [CI] 1.281–1.433) and IS (OR = 1.351, 95% CI 1.295–1.409), and LDL‐C with IHD (OR = 1.610, 95% CI 1.508–1.719); these met the Bonferroni threshold. Fasting glucose showed nominal evidence for IHD, whereas fasting glucose and LDL‐C showed no statistically significant associations with overall IS. Conclusions: IHD and IS burdens declined across Europe, but regional inequalities persisted. GBD attribution and MR provide complementary evidence; cardiometabolic risks remain central, while genetic associations differ between IHD and overall IS.
- Open Access
- 1 October 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-8
Quantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023–2029: A Global Burden of Disease Study 2023 Analysis
Background: Migraine is a significant public health issue and a leading cause of disability globally. This study quantified the health and productivity burden of migraine among women aged 20– 64 years in Western Europe from 2023 to 2029. Methods: We used a Bayesian productivity-adjusted life-year framework with archived Bayesian age-period-cohort projections. Data were derived from Global Burden of Disease Study 2023 estimates. The analysis included disability-adjusted life years (DALYs), estimated productivity-adjusted life years (PALYs) lost, and productivity-related monetary valuation in 2021 constant international dollars (Int$), discounted to 2023. Results: From 2023 to 2029, the age-specific inputs summed to 10.867 million DALYs and 1.082 million estimated PALYs lost. The cumulative monetary valuation was Int$69.85 billion, and sensitivity estimates ranged from Int$66.07 billion to Int$76.32 billion. In a separate female age-standardized comparison, Belgium had the highest available 2023 country estimate at 1443.61 DALYs per 100,000 women. Conclusion: Migraine represents a substantial health and productivity burden among working-age women in Western Europe. The monetary estimate depends on the archived coefficients and valuation inputs and should not be interpreted as observed GDP loss or treatment-attributable savings.
- 1 October 2026
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 19, 1-8
Open AccessQuantifying the Health and Productivity Burden of Migraine Among Working-Age Women in Western Europe, 2023–2029: A Global Burden of Disease Study 2023 Analysis
Background: Migraine is a significant public health issue and a leading cause of disability globally. This study quantified the health and productivity burden of migraine among women aged 20– 64 years in Western Europe from 2023 to 2029. Methods: We used a Bayesian productivity-adjusted life-year framework with archived Bayesian age-period-cohort projections. Data were derived from Global Burden of Disease Study 2023 estimates. The analysis included disability-adjusted life years (DALYs), estimated productivity-adjusted life years (PALYs) lost, and productivity-related monetary valuation in 2021 constant international dollars (Int$), discounted to 2023. Results: From 2023 to 2029, the age-specific inputs summed to 10.867 million DALYs and 1.082 million estimated PALYs lost. The cumulative monetary valuation was Int$69.85 billion, and sensitivity estimates ranged from Int$66.07 billion to Int$76.32 billion. In a separate female age-standardized comparison, Belgium had the highest available 2023 country estimate at 1443.61 DALYs per 100,000 women. Conclusion: Migraine represents a substantial health and productivity burden among working-age women in Western Europe. The monetary estimate depends on the archived coefficients and valuation inputs and should not be interpreted as observed GDP loss or treatment-attributable savings.
- Open Access
- 1 September 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-12
The Health and Productivity Impact of Thyroid Diseases Among Working-Age Women in Western Europe
Background: Hypothyroidism and hyperthyroidism are common but clinically distinct disorders that can impair work through fatigue, cognitive slowing, mood symptoms, weakness, palpitations, and heat intolerance. We quantified the health and formal-labor-market productivity burden of the combined Global Burden of Disease (GBD) thyroid-diseases category among working-age women in Western Europe. Methods: Historical epidemiological estimates for women aged 20– 64 years in 24 Western European countries were obtained from GBD 2023 for 1990– 2023. Joinpoint regression and locally weighted smoothing characterized temporal and sociodemographic patterns. A Bayesian age-period-cohort model based on the 1990– 2023 series projected years lived with disability and years of life lost for 2024– 2029; the 2023 estimate was retained as the baseline. Projected health loss was translated into productivity-adjusted life-years and discounted gross domestic product losses using a Bayesian productivity-adjusted life-year framework. Results: In 2023, the age-standardized disability-adjusted life-year rate ranged from 56.26 per 100,000 women in Spain (95% uncertainty interval, 29.22– 96.78) to 107.71 in Norway (55.61– 187.94). The regional rate changed little during 1990– 2023 (average annual percent change, − 0.06%) but followed six distinct temporal segments. Annual years lived with disability were projected to decline from 108.07 thousand (95% credible interval, 107.18– 108.96) in 2023 to 102.55 thousand (90.44– 114.66) in 2029, whereas years of life lost were projected to increase from 5.40 thousand (5.21– 5.59) to 6.13 thousand (3.68– 8.58). Across 2023– 2029, cumulative productivity loss was 127.48 thousand productivity-adjusted life-years (112.70– 142.26), equivalent to Int$8.23 billion in discounted gross domestic product (7.27– 9.18). Conclusion: The combined noncancer thyroid-diseases category produces a persistent disability-dominated burden and substantial estimated losses in formal-market productivity among working-age women in Western Europe. The estimates should not be interpreted as subtype-specific or as including unpaid, caregiving, informal-sector, or thyroid-cancer-related losses.
- 1 September 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-12
Open AccessThe Health and Productivity Impact of Thyroid Diseases Among Working-Age Women in Western Europe
Background: Hypothyroidism and hyperthyroidism are common but clinically distinct disorders that can impair work through fatigue, cognitive slowing, mood symptoms, weakness, palpitations, and heat intolerance. We quantified the health and formal-labor-market productivity burden of the combined Global Burden of Disease (GBD) thyroid-diseases category among working-age women in Western Europe. Methods: Historical epidemiological estimates for women aged 20– 64 years in 24 Western European countries were obtained from GBD 2023 for 1990– 2023. Joinpoint regression and locally weighted smoothing characterized temporal and sociodemographic patterns. A Bayesian age-period-cohort model based on the 1990– 2023 series projected years lived with disability and years of life lost for 2024– 2029; the 2023 estimate was retained as the baseline. Projected health loss was translated into productivity-adjusted life-years and discounted gross domestic product losses using a Bayesian productivity-adjusted life-year framework. Results: In 2023, the age-standardized disability-adjusted life-year rate ranged from 56.26 per 100,000 women in Spain (95% uncertainty interval, 29.22– 96.78) to 107.71 in Norway (55.61– 187.94). The regional rate changed little during 1990– 2023 (average annual percent change, − 0.06%) but followed six distinct temporal segments. Annual years lived with disability were projected to decline from 108.07 thousand (95% credible interval, 107.18– 108.96) in 2023 to 102.55 thousand (90.44– 114.66) in 2029, whereas years of life lost were projected to increase from 5.40 thousand (5.21– 5.59) to 6.13 thousand (3.68– 8.58). Across 2023– 2029, cumulative productivity loss was 127.48 thousand productivity-adjusted life-years (112.70– 142.26), equivalent to Int$8.23 billion in discounted gross domestic product (7.27– 9.18). Conclusion: The combined noncancer thyroid-diseases category produces a persistent disability-dominated burden and substantial estimated losses in formal-market productivity among working-age women in Western Europe. The estimates should not be interpreted as subtype-specific or as including unpaid, caregiving, informal-sector, or thyroid-cancer-related losses.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-12
Temporal Trends and Model-Based Projections of Female-Specific Cancer Burden Among East Asian Women Aged 55 Years and Older: A GBD 2023 Analysis
Population aging may substantially influence the burden of female-specific cancers in East Asia. This study assessed temporal trends and model-based projections of breast, cervical, ovarian, and uterine cancer burden among women aged 55 years and older in China, Japan, and South Korea using Global Burden of Disease Study 2023 estimates. We analyzed age-standardized incidence, mortality, and disability-adjusted life-year rates from 1990 to 2023. Joinpoint regression was used to evaluate historical temporal trends, and autoregressive integrated moving average models were applied to generate model-based projections through 2040. Attributable risk factor patterns were described using the GBD comparative risk assessment framework. Breast cancer accounted for the largest burden among the four cancer types across the three countries in 2023. Cervical cancer generally showed declining trends, although the magnitude and timing of these changes varied by country. Ovarian and uterine cancer burdens were relatively higher in Japan and South Korea than in China. Model-based projections suggested that the burden of breast, ovarian, and uterine cancers may remain substantial through 2040, particularly in Japan and South Korea. In the GBD risk attribution framework, high body mass index and metabolic risks showed increasing contributions to selected hormone-related cancers, whereas unsafe sex remained the major attributable risk factor for cervical cancer. Female-specific cancer burden among women aged 55 years and older in East Asia showed marked heterogeneity across countries and cancer types. These findings should be interpreted as descriptive estimates and model-based projections rather than causal evidence or deterministic predictions. Strengthening age-appropriate screening, HPV-related prevention, metabolic risk management, and continued surveillance may help inform future cancer control strategies in aging East Asian populations.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-12
Open AccessTemporal Trends and Model-Based Projections of Female-Specific Cancer Burden Among East Asian Women Aged 55 Years and Older: A GBD 2023 Analysis
Population aging may substantially influence the burden of female-specific cancers in East Asia. This study assessed temporal trends and model-based projections of breast, cervical, ovarian, and uterine cancer burden among women aged 55 years and older in China, Japan, and South Korea using Global Burden of Disease Study 2023 estimates. We analyzed age-standardized incidence, mortality, and disability-adjusted life-year rates from 1990 to 2023. Joinpoint regression was used to evaluate historical temporal trends, and autoregressive integrated moving average models were applied to generate model-based projections through 2040. Attributable risk factor patterns were described using the GBD comparative risk assessment framework. Breast cancer accounted for the largest burden among the four cancer types across the three countries in 2023. Cervical cancer generally showed declining trends, although the magnitude and timing of these changes varied by country. Ovarian and uterine cancer burdens were relatively higher in Japan and South Korea than in China. Model-based projections suggested that the burden of breast, ovarian, and uterine cancers may remain substantial through 2040, particularly in Japan and South Korea. In the GBD risk attribution framework, high body mass index and metabolic risks showed increasing contributions to selected hormone-related cancers, whereas unsafe sex remained the major attributable risk factor for cervical cancer. Female-specific cancer burden among women aged 55 years and older in East Asia showed marked heterogeneity across countries and cancer types. These findings should be interpreted as descriptive estimates and model-based projections rather than causal evidence or deterministic predictions. Strengthening age-appropriate screening, HPV-related prevention, metabolic risk management, and continued surveillance may help inform future cancer control strategies in aging East Asian populations.
- Open Access
- 1 February 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Dietary micronutrients, whole food patterns, and restless legs syndrome in coronary heart disease: A dual dietary profiling machine learning analysis using NHANES data
Background: The relationships between dietary patterns and restless legs syndrome (RLS) risk in patients with coronary heart disease (CHD) are poorly understood. This study aimed to identify dietary factors associated with RLS risk in this specific population. Methods: We analyzed NHANES data (2005–2018) using two complementary dietary representations: micronutrient profiles and food-group profiles derived from the MyPyramid Equivalents Database linked to NHANES dietary recalls. Six machine-learning models were developed using Boruta for feature selection and SMOTE to address class imbalance. Model robustness was further evaluated through temporal validation, and SHAP and LIME were used for model interpretation. Results: Random forest demonstrated the highest predictive performance in both micronutrient and food-group models. SHAP analysis indicated that Lycopene, Caffeine, Alpha-carotene, Vitamin C, Food folate, and Magnesium showed contributions toward lower predicted RLS probability, whereas Calcium, Moisture, and Vitamin B1 showed contributions toward higher predicted RLS probability. These model-derived directions represent associations rather than causal effects. In the food-group model, total red and orange vegetables, total vegetables, and white potatoes were inversely associated with RLS. Conversely, Milk, Meat, and Added Sugars were positively associated with predicted RLS probability. Conclusion: Random forest models effectively identify dietary risk factors for RLS in CHD patients. Nutrient-dense dietary patterns, particularly those characterized by higher consumption of specific vegetables and antioxidant-related nutrients, were associated with lower predicted RLS probability, whereas higher consumption of milk, meat, and added sugars was associated with higher predicted RLS probability. These findings suggest that dietary patterns characterized by specific nutrient and food-group profiles may be associated with RLS risk among CHD patients and warrant further investigation in independent prospective studies.
- 1 February 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Open AccessDietary micronutrients, whole food patterns, and restless legs syndrome in coronary heart disease: A dual dietary profiling machine learning analysis using NHANES data
Background: The relationships between dietary patterns and restless legs syndrome (RLS) risk in patients with coronary heart disease (CHD) are poorly understood. This study aimed to identify dietary factors associated with RLS risk in this specific population. Methods: We analyzed NHANES data (2005–2018) using two complementary dietary representations: micronutrient profiles and food-group profiles derived from the MyPyramid Equivalents Database linked to NHANES dietary recalls. Six machine-learning models were developed using Boruta for feature selection and SMOTE to address class imbalance. Model robustness was further evaluated through temporal validation, and SHAP and LIME were used for model interpretation. Results: Random forest demonstrated the highest predictive performance in both micronutrient and food-group models. SHAP analysis indicated that Lycopene, Caffeine, Alpha-carotene, Vitamin C, Food folate, and Magnesium showed contributions toward lower predicted RLS probability, whereas Calcium, Moisture, and Vitamin B1 showed contributions toward higher predicted RLS probability. These model-derived directions represent associations rather than causal effects. In the food-group model, total red and orange vegetables, total vegetables, and white potatoes were inversely associated with RLS. Conversely, Milk, Meat, and Added Sugars were positively associated with predicted RLS probability. Conclusion: Random forest models effectively identify dietary risk factors for RLS in CHD patients. Nutrient-dense dietary patterns, particularly those characterized by higher consumption of specific vegetables and antioxidant-related nutrients, were associated with lower predicted RLS probability, whereas higher consumption of milk, meat, and added sugars was associated with higher predicted RLS probability. These findings suggest that dietary patterns characterized by specific nutrient and food-group profiles may be associated with RLS risk among CHD patients and warrant further investigation in independent prospective studies.
- 22 December 2025
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (3) , 2123-2137
Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis
Background: Non‐alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are two core diseases in metabolic syndrome, with a notable rise in their global prevalence, especially in Europe. Despite differences in clinical presentation, both share common pathogenic mechanisms and often occur comorbidly. Understanding the epidemiological patterns of NAFLD and T2DM at different socio‐economic levels, as well as the causal relationships between key risk factors, is crucial for developing effective public health intervention strategies. Methods: This study, based on the Global Burden of Disease (GBD) 2023, integrates the MG randomisation (MR) approach to systematically assess the epidemiological characteristics, spatiotemporal trends, and their relationship with socio‐demographic index (SDI) in the European region from 1990 to 2023. Risk factor attribution analysis was conducted using the GBD model, while MR analysis employed the two‐sample MR method to explore the causal effects of key metabolic and behavioural factors. Results: The results revealed a significant spatial congruence in the distribution of NAFLD and T2DM across Europe. Joinpoint regression analysis indicated that both diseases followed similar temporal trajectories, characterised by a sustained increase in disease burden within Central and Eastern Europe since 1990. Age‐decomposition analysis demonstrated that although the predominant burden remains concentrated among middle‐aged and elderly populations, there is a discernible trend towards younger onset for both conditions. Furthermore, the distribution of NAFLD and T2DM across different SDI levels exhibited analogous patterns, revealing an inverted U‐shaped association where the highest disease burdens were observed not in the most developed nations, but in high‐middle SDI countries currently undergoing rapid nutritional and lifestyle transitions. Risk factor attribution analysis identified high body mass index (BMI), elevated fasting plasma glucose, and smoking as the primary modifiable risk factors for both diseases. MR analysis further confirmed that waist circumference acts as a pivotal shared causal determinant, yielding odds ratios of 2.02 and 3.76, respectively, which were significantly higher than those of other variables. Conclusion: This study represents the inaugural integration of GBD 2023 database with MR analysis, systematically elucidating the disease burden trends of NAFLD and T2DM in Europe. The findings precisely characterise the co‐morbidity patterns of these two metabolic diseases, highlighting a synergistic effect on disease burden in Central and Eastern Europe that is highly correlated with the region's rapid socio‐economic transition. Epidemiological evidence further indicates an accelerating upward trend in the incidence of these diseases among younger populations. Crucially, MR analysis identifies abdominal obesity, quantified by waist circumference, as the dominant causal link between NAFLD and T2DM. Notably, its effect magnitude significantly exceeds that of general BMI or genetic susceptibility. Based on these findings, the study emphasises an urgent need for public health and clinical practice to transition from single‐disease management models to integrated metabolic care strategies. Specifically, priority should be given to interventions focused on reducing abdominal fat and implementing early screening among high‐risk young populations. This strategy holds promise for effectively curbing the spread of metabolic diseases in Europe and alleviating future public health burdens.
- 22 December 2025
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (3) , 2123-2137
Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis
Background: Non‐alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) are two core diseases in metabolic syndrome, with a notable rise in their global prevalence, especially in Europe. Despite differences in clinical presentation, both share common pathogenic mechanisms and often occur comorbidly. Understanding the epidemiological patterns of NAFLD and T2DM at different socio‐economic levels, as well as the causal relationships between key risk factors, is crucial for developing effective public health intervention strategies. Methods: This study, based on the Global Burden of Disease (GBD) 2023, integrates the MG randomisation (MR) approach to systematically assess the epidemiological characteristics, spatiotemporal trends, and their relationship with socio‐demographic index (SDI) in the European region from 1990 to 2023. Risk factor attribution analysis was conducted using the GBD model, while MR analysis employed the two‐sample MR method to explore the causal effects of key metabolic and behavioural factors. Results: The results revealed a significant spatial congruence in the distribution of NAFLD and T2DM across Europe. Joinpoint regression analysis indicated that both diseases followed similar temporal trajectories, characterised by a sustained increase in disease burden within Central and Eastern Europe since 1990. Age‐decomposition analysis demonstrated that although the predominant burden remains concentrated among middle‐aged and elderly populations, there is a discernible trend towards younger onset for both conditions. Furthermore, the distribution of NAFLD and T2DM across different SDI levels exhibited analogous patterns, revealing an inverted U‐shaped association where the highest disease burdens were observed not in the most developed nations, but in high‐middle SDI countries currently undergoing rapid nutritional and lifestyle transitions. Risk factor attribution analysis identified high body mass index (BMI), elevated fasting plasma glucose, and smoking as the primary modifiable risk factors for both diseases. MR analysis further confirmed that waist circumference acts as a pivotal shared causal determinant, yielding odds ratios of 2.02 and 3.76, respectively, which were significantly higher than those of other variables. Conclusion: This study represents the inaugural integration of GBD 2023 database with MR analysis, systematically elucidating the disease burden trends of NAFLD and T2DM in Europe. The findings precisely characterise the co‐morbidity patterns of these two metabolic diseases, highlighting a synergistic effect on disease burden in Central and Eastern Europe that is highly correlated with the region's rapid socio‐economic transition. Epidemiological evidence further indicates an accelerating upward trend in the incidence of these diseases among younger populations. Crucially, MR analysis identifies abdominal obesity, quantified by waist circumference, as the dominant causal link between NAFLD and T2DM. Notably, its effect magnitude significantly exceeds that of general BMI or genetic susceptibility. Based on these findings, the study emphasises an urgent need for public health and clinical practice to transition from single‐disease management models to integrated metabolic care strategies. Specifically, priority should be given to interventions focused on reducing abdominal fat and implementing early screening among high‐risk young populations. This strategy holds promise for effectively curbing the spread of metabolic diseases in Europe and alleviating future public health burdens.